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Structural characterization of 
site-modified nanocapsid with 
monodispersed gold clusters
Marie C Stark1,2, Mo A Baikoghli2, Tanja Lahtinen3, Sami Malola4, Li Xing1, Michelle Nguyen2, 
Marina Nguyen2, Aria Sikaroudi2, Varpu Marjomäki1, Hannu Häkkinen3,4 & R Holland Cheng1,2
Hepatitis E Virus-like particles self-assemble in to noninfectious nanocapsids that are resistant 
to proteolytic/acidic mucosal delivery conditions. Previously, the nanocapsid was engineered to 
specifically bind and enter breast cancer cells, where successful tumor targeting was demonstrated 
in animal models. In the present study, the nanocapsid surface was modified with a solvent-exposed 
cysteine to conjugate monolayer protected gold nanoclusters (AuNC). Unlike commercially available 
gold nanoparticles, AuNCs monodisperse in water and are composed of a discrete number of gold 
atoms, forming a crystalline gold core. Au102pMBA44 (Au102) was an ideal conjugate given its small 
2.5 nm size and detectability in cryoEM. Au102 was bound directly to nanocapsid surface cysteines via 
direct ligand exchange. In addition, Au102 was functionalized with a maleimide linker (Au102_C6MI) for 
maleimide-thiol conjugation to nanocapsid cysteines. The AuNC-bound nanocapsid constructs were 
conjugated in various conditions. We found Au102_C6MI to bind nanocapsid more efficiently, while Au102 
remained more soluble over time. Nanocapsids conjugated to Au102_C6MI were imaged in cryoEM for 
single particle reconstruction to localize AuNC position on the nanocapsid surface. We resolved five 
unique high intensity volumes that formed a ring-shaped density at the 5-fold symmetry center. This 
finding was further supported by independent rigid modeling.
Biological constructs with multiple axes of symmetry, such as viruses, are widely used as scaffolds to orient mol-
ecules in a uniform arrangement1,2. Chemical conjugation is an efficient method to selectively bind naturally 
occurring and synthetic molecules to a biological complex. The structural protein of Hepaptis E Virus (HEV) 
self assembles in to a highly stable icosahedral capsid. Because HEV is a fecal-orally transmitted virus, assembled 
HEV capsid protein (HEV nanocapsid) can withstand harsh proteolytic and acidic oral delivery conditions3,4. 
Previously, fluorescently labeled HEV nanocapsids bound to tumor-specific peptides were shown to target tumor 
tissue in animal models5,6. This proof-of-concept study demonstrated the diagnostic potential of chemically mod-
ified HEV nanocapsids.
In the present study, virus-like particles of HEV nanocapsids engineered with a surface-exposed cysteine were 
bound to molecule-like gold nanoclusters. Gold nanoparticles (AuNPs) are universal labeling tools for biological 
imaging due to their low toxicity, high solubility, contrast properties, and unique light absorbance spectra7,8. 
AuNPs function as contrast agents in electron microscopy (EM) as their electron-dense gold core generates high 
phase and amplitude contrast, distinguishing AuNPs from biological material. Some AuNPs have plasmonic and 
near-infrared absorbance (NIR), a well-described diagnostic imaging signal detectable in deep-tissue samples and 
in vivo7–11. Therapeutic applications to localize the photo-thermal effect of AuNPs are also being explored7,9,12,13. 
Monolayer-protected gold nanoclusters (AuNCs) are distinct from traditional AuNPs such as colloidal AuNPs 
and Nanogold®. At a nanoscale, solubilized colloidal gold is relatively large, heterogeneous in solution and either 
non-specifically binds biomaterial or requires extended functionalized linkers, limiting the achievable resolution 
in EM imaging14,15.
This work reports the first successful Murray place exchange conjugation of AuNCs to a large icosahe-
dral complex. In earlier studies, AuNC was indirectly localized to a N9 neuraminidase protomer through an 
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intermediate Fab fragment conjugated to AuNC16. These AuNC-protein complexes were imaged in EM and struc-
turally characterized with single particle reconstruction. The reconstruction results from this work demonstrated 
the rigidity of protein-bound AuNCs and suggested larger macromolecules could bind AuNCs functionalized 
with short linkers.
In the present study, we resolved the structure of a large icosahedral complex bound to AuNCs functional-
ized with short linkers. The AuNC used in this study, Au102pMBA44 (Au102), has a 1.5 nm gold core composed 
of 102 gold atoms. Protected by 44 thiolate ligands, p-mercaptobenzoic acid (pMBA), Au102 is about 2.5 nm in 
diameter. Properties of Au102 such as structure, surface charge distribution, and deprotonation effects in water 
have been extensively characterized17–20. Like other thiol-protected AuNCs, Au102 is monodispersed in water and 
exhibits a distinct light absorbance profile20–22. Previously, Au102 was functionalized with a thiol-reactive linker, 
N-(6-hydroxyhexyl)maleimide (Au102_C6MI), to bind native enteroviruses cysteines23. Because native cysteine 
residues were located just below capsid surface, linker-functionalization was necessary to access the enterovirus 
cysteines. Enteroviruses bound Au102_C6MI without impairing virus infection, but a two-day incubation at 37 °C 
was necessary to bind available cysteine sites. These enterovirus conjugation studies provided the ground work 
for AuNC conjugation to surface-engineered nanocapsid.
The current study aims to investigate conjugation efficiency and the 3D structure of AuNC-bound nanocap-
sids. Native HEV lacks surface exposed cysteine residues, so conjugation was limited to the engineered cysteine 
sites. This site-specific conjugation enabled more precise tuning of the nanocapsid surface. Au102 was bound 
to nanocapsids through direct ligand exchange while Au102_C6MI was bound via maleimide-thiol conjuga-
tion. Nanocapsids self-assemble to form an empty T = 1 icosahedral capsid composed of a S, M, and P domain 
(Fig. 1a). The S and M domains provide an icosahedral base from which the surface P-domain extends from a 
proline-rich flexible hinge24,25. The P domain forms a spike protruding away from the capsid shell, stabilizing 
P domain surface interactions such as chemical conjugation. After conjugation efficiency and stability assess-
ment, AuNC-bound nanocapsids were imaged for 3D structure evaluation. Using cryoEM data from Au102_
C6MI-bound nanocapsids, a 3D density map of AuNC-bound nanocapsids was resolved through single particle 
reconstruction (SPR). Conjugation efficiency and structural analysis are critical to the development of a stable 
nanocapsid delivery platform.
Results
Previously, five cysteine replacement sites were evaluated based on surface exposure, structural flexibility, as well 
as epitope antigenicity and cell-binding6. Based on previous research6,26 and preliminary screening of AuNC con-
jugation to various constructs, we selected HEV nanocapsid 573 C to bind AuNCs. 573 C is located on the outer 
edge of the nanocapsid dimer, just below the upper tip, such that five 573 C sites face the 5-fold symmetry center 
(Fig. 1b). The proximity of 573 C to the 5-fold cavity exposes cysteine sites to bind contrast molecules, but leaves 
the top of the dimer surface available for additional cell-targeting modulation. Nanocapsids were conjugated to 
Au102 and Au102_C6MI via ligand exchange and maleimide-thiol coupling, respectively (Fig. 1c).
Gold Nanocluster Conjugation. Purified AuNCs, Au102 and Au102_C6MI, were both solubilized in sterile 
ddH20. Gel electrophoresis of water solubilized AuNCs confirmed the adequate size and homogeneity of the gold 
clusters15,27 as depicted in Fig. 2a (full gel in Figure S1a). Confirmation of the functionalization with Au102_C6MI 
was suggested by smeared banding in polyacrylamide gel23. The distinctive brown color of AuNCs, arising from 
the size of the gold core, remained unchanged in the C6MI functionalized Au10215,22. AuNCs were imaged with EM 
to confirm the expected cluster diameter and uniform size coinciding with previous imaging results28.
Nanocapsids were bound to AuNCs at RT and samples were passed through a column containing size exclu-
sion chromatography resin for fraction collection. As a crude size exclusion method, this procedure only effec-
tively removes small, unbound AuNCs which remain in column resin. The large size of nanocapsids was beyond 
the resolvable limit of the resin used, which tended to result in a broad elution curve. However, there was a 
consistent elution profile where disassembled nanocapsids eluted in later fractions than assembled nanocapsids 
and unbound nanocapsids eluted in later fractions than AuNC-bound nanocapsids (Fig. 2b). Spectrophotometry 
Figure 1. Schematic for nanocapsid and AuNC cysteine conjugation. (a) X-Ray cystral structure of 
nanocapsid dimer highlighting 573 C binding site on the nancapsid P-domain. (b) When dimer building blocks 
associate to form a pentamer, 573 C sites faces the 5-fold center. The crystal structure of this pentamer was 
docked over a surface rendition of the full T = 1 nanocapsid crystal structure36. (c) The cysteine-reactive sites on 
AuNC constructs23 are depicted with a black arrow, illustrating cysteine replacement site for Au102 (top) and the 
maleimide-thiol coupling site in Au102_C6MI (bottom).
www.nature.com/scientificreports/
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measurements at absorbance values of 280 nm and 420 nm wavelengths (A280nm and A420nm) were acquired for 
each fraction. As pure protein, unbound nanocapsids absorbance signal peaks at A280nm but do not absorb 420 nm 
light. AuNCs have been shown to absorb light across a broad UV-vis spectrum, with particularly high 280 nm 
light absorbance15,19. Using Au102-specific extinction coefficients20, A420nm values were measured to determine the 
concentration of AuNC in a sample14,20. For a nanocapsid + AuNC sample, A280nm measurements alone could 
not be used to determine protein concentration. Instead, the A420nm measurement was used to infer the expected 
A280nm absorbance for AuNC without protein. The expected A280nm value was subtracted from the measured 
A280nm value to determine protein concentration (see Equation 1 in Experimental Procedures). From fractions 
with detectable A420nm values, often accompanied by a visible yellow-brown color in solution, the presence of 
nanocapsid protein was confirmed by SDS-PAGE. TEM imaging confirmed the icosahedral structure of nano-
capsid remained intact.
Assembled nanocapsids, disassembled nanocapsids, AuNC, and nanocapsids bound to AuNC for 24 h 
were run through size exclusion columns for fraction collection. Unbound AuNC remained in the column 
(Figure S2a) and absorbance measurements were acquired for the other sample fractions (Fig. 2b). A280nm for 
AuNC-bound nanocapsid was significantly higher than that of assembled and disassembled nanocapsids, which 
had no detectable A420nm signal. Disassembled nanocapsids eluted in later fractions than assembled nanocap-
sids peaking at A280nm = 0.038 and A280nm = 0.024, respectively. A280nm and A420nm values were slightly higher for 
Au102_C6MI-bound nanocapsids than Au102-bound nanocapsids, peaking at A280nm = 0.085 and A280nm = 0.057, 
respectively.
Following overnight conjugation, Au102_C6MI partially precipitated in solution while Au102 remained fully 
soluble. For Au102 conjugation, pre-incubating the nanocapsid with TCEP (tris(2-carboxyethyl)phosphine) 
resulted in an increased molar ratio of bound AuNCs to available binding sites (TCEP-free data not shown). 
Non-reducing SDS-PAGE (Fig. 2C) was run to confirm the presence of two distinct protein bands: an unbound, 
52 kDa nanocapsid subunit and a ~56 kDa AuNC-bound subunit (full gel in Figure S1b). Prior to coomassie 
staining of gels, a coffee colored band was apparent around 56 kDa. Both the nanocapsid and AuNC-bound 
nanocapsid bands were visible after coomassie blue staining. 5 h conjugation samples were also run through size 
Figure 2. Characterization of AuNC and screening for conjugation to nanocapsid. (a) AuNCs solubilized in 
neutral buffer and visualized in plastic micro tubes (top) and run through native PAGE (bottom). (b) A280nm 
(top) and A420nm (bottom) nanodrop readings for size exclusion fractions of AuNC-bound and unbound 
nanocapsids. (c) Non-reducing SDS-PAGE before (1a–3a) and after (1b–3b) coomassie blue staining. (c,d) 
Non-reducing SDS PAGE gels of AuNC-bound nanocapsids samples bound for ON (c) and 5 h (d) where black 
arrows indicate to nanocapsid banding (~52 kDa) and gold arrows indicate AuNC-bound nanocapsid banding 
(~56 kDa). (e) Au102 occupancy on nanocapsid surface. Percent occupancy determined molar ratio of (AuNC): 
(nanocapsid binding sites) based on UV-vis as described in Equation 1. (f) CryoEM images of AuNC-bound 
nanocapsids.
www.nature.com/scientificreports/
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exclusion chromatography (Figure S2b) and in SDS-PAGE (Fig. 2d) suggesting Au102_C6MI binding efficiency 
was higher than that of Au102 over shorter conjugation time. After 5hr and ON conjugation, protein and AuNC 
concentration were calculated using previously described concentration calculations14,20 (Fig. 2e) and summa-
rized in Equation 1. Among peak A420 nm fractions for Au102, average binding occupancy was 13.1% and 18.9% 
after 5 hour and overnight conjugation, respectively, while Au102C6MI average binding occupancy was 35.5% and 
22.1%, respectively.
Nanocapsids conjugated to AuNC were imaged in cryoEM (Fig. 2f). For observation purposes in cryoEM, 
optimal defocus values were distinct for nanocapsid protein and AuNC. Nanocapsids conjugated to AuNCs 
in Tris-NaCl pH = 7.5 appeared linked together in cryoEM, while nanocapsids conjugated to AuNC in MES 
pH = 6.5 were better dispersed (Figure S2c). Freshly prepared AuNCs and AuNCs prepared several months ear-
lier were solubilized in MES and Tris-NaCl. Initial concentration was determined with A420 nm measurement 
followed by a second A420 nm measurement after one day and one week in solution (Figure S2d). These results 
suggested, particularly for older AuNC preparations, Au102_C6MI exhibited the most significant precipitation in 
Tris-NaCl whereas Au102 remained soluble in all buffer conditions.
Rigid Modeling of AuNC Position on Nanocapsid 5-fold. To model where AuNC densities could local-
ize on the nanocapsid surface, rigid modeling of AuNC-bound nanocapsid was performed independent of the 
3D reconstruction results (Fig. 3). The model described probable accessible positions for AuNC densities on the 
nanocapsid surface. The parameters of this model were based on length of C6MI linker, the nanocapsid binding 
site (573C), nanocapsid x-ray crystal structure29, and the radial density of Au102. The radial density of Au102 was 
constructed from the coordinates of atoms weighted by the atomic number, normalization to a spherical area, 
and Gaussian broadening. Accessible positions on the nanocapsid surface were illustrated using spherical probes 
of specified size range representing the effective size of Au102_C6MI. The density of AuNCs (colored gold) was 
built on the surface of nanocapsid crystal structure (colored gray) by adding the modeled electron density of 
Au102 at each accessible position. This modelling assumed each position of Au102_C6MI had equal probability 
and restricted spherical probe densities from overlapping with nanocapsid coordinates within van der Waals 
radii of atoms. Positions for the AuNCs were allowed within a specified distance range from the N573C binding 
site contingent on the length of the pMBA surface plus the C6MI linker. Three separate distance parameters were 
implemented for rigid modeling (Fig. 3a–c) as follows: probe radii distance and binding site to probe center dis-
tance (3a) 1.6–3.0 nm and <3.0 nm; (3b) 1.6–2.6 nm and 2.1–3.7 nm; (3c) 1.6–2.9 nm and <4.2 nm, respectively.
In the first model (Fig. 3a), the maximum distance parameter between binding site to probe center closely 
resembled the atomic length Au102_C6MI measured from maleimide end to gold core. With parameters that 
matched static atomic structures, the first model assumed little to no nanocapsid structural change. Potential 
structural changes, particularly to the P-domain, upon AuNC conjugation, were also considered. To account for 
the possible movement of the cysteine binding site upon conjugation, we also modeled slightly increased distance 
ranges between binding site and gold core in Fig. 3b, with the most extreme range shown in Fig. 3c. The rigid 
modeling suggested AuNC likely localized near the nanocapsid 5-fold cavity, forming a ring-like structure around 
the 5-fold symmetry center.
3D Reconstruction of AuNC Conjugated Nanocapsid. CryoEM micrographs of Au102_C6MI-bound 
nanocapsids were collected to generate a data set for Single Particle Reconstruction (SPR). Semi-automated par-
ticle selection methods were used to select a total of 5,276 particles for refinement and reconstruction. Iterative 
de novo initial models were generated to determine and cross-validate the particle parameters30. To optimize 
the 2D alignment and orientation during refinement, a polar Fourier transform (PFT) method with radial range 
pushed to 10 Å beyond the particle edge was implemented in conjunction with center search31–33. 3D reconstruc-
tion methods were performed with imposed icosahedral symmetry and raw data is shown in Figure S3. In the 
resulting icosahedral density map, the S, M, and P domains of the nanocapsid were clearly resolved (Fig. 4a). In 
addition to reconstructing distinct features of a T = 1 HEV nanocapsid, five unique high-intensity regions were 
identified around the nanocapsid five-fold and localized to twelve icosahedral vertices. For validation purposes, 
3D reconstruction of unbound nanocapsid was performed in parallel with AuNC-bound nanocapsid (Figure S4). 
Both density maps manifested the same structural S, M, and P domain features, except the unbound nanocapsid 
map did not display a high-intensity 5-fold volume.
Local intensity analysis indicated the high intensity regions were distinguishable from the protein, forming a 
ring-like cluster around the nanocapsid 5-fold axes. These intensities were observed slightly above the S domain 
around the 5-fold axes. In the 3D reconstruction, the ring-like cluster that was 6 nm in diameter was comprised 
of five individual densities, each 2.5 nm in diameter (Fig. 4b,c). The distance between the center a given AuNC 
density and the nearest 573 C binding site was about 2–3 nm. The localization of unique AuNC densities was 
validated with difference mapping between the resolved structures of AuNC-bound nanocapsid and unbound 
nanocapsid (Figure S4) as well as intensity analysis (Fig. 4d,e). Local intensity profiling characterized the differ-
ence in intensity peaks around the 5-fold. The AuNC-bound map displayed distinctive high intensity peaks cor-
responding to the ring-like distribution of AuNCs, slightly above the S domain density (Fig. 4d). These intensities 
were quantified in a 1D graph to assess the local intensity differences between AuNC-bound nanocapsid and 
native nanocapsid (Fig. 4e).
To visualize AuNC conjugation, we modeled Au102 crystal structures19 on the nanocapsid surface based on the 
5-fold AuNC densities resolved in our 3D reconstruction (Fig. 5a). 3D reconstruction with icosahedral symmetry 
will generate symmetric AuNC densities at each 5-fold, and therefore appear as 100% AuNC binding. However, 
100% AuNC conjugation is unlikely and was not supported by the spectrophotometric and SDS-PAGE data. To 
assess the relative density distribution at the 5-fold without imposed icosahedral symmetry, we implemented 
relaxed symmetry into reconstruction refinement. Of high intensity volumes resolved in the relaxed symmetry 
www.nature.com/scientificreports/
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Figure 3. Rigid modeling of Au102_C6MI conjugation to the nanocapsid binding site. Three rigid models 
illustrate probable positions of AuNCs on the nanocapsid surface within specified distance parameters 
determined by Au102_C6MI atomic structure and the cysteine binding site. The density of AuNCs (colored gold) 
was built on the surface of nanocapsid crystal structure (colored gray) by adding the modeled electron density 
of Au102 at each accessible position with a specified distance from the binding site (pink). (a–c) The left image 
shows nanocapsids with modeled AuNC densities and the AuNC densities alone on the right. The upper image 
is a top view of the 5-fold symmetry center while the bottom shows a side view of the 5-fold symmetry center. 
Probe radii distance and binding site to probe center distance parameters for each model were as follows: (a) 
1.6–3.0 nm and <3.0 nm; (b) 1.6–2.6 nm and 2.1–3.7 nm; (c) 1.6–2.9 nm and <4.2 nm, respectively. Red arrow 
scale bar is 4.5 nm.
www.nature.com/scientificreports/
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structure, the relative position of 5-fold densities matched that of the imposed symmetry structure. Radial cue-
ing analysis showed a heterogeneous distribution of intensity peaks around the 12 nanocapsid 5-fold vertices 
(Fig. 5b). Heterogeneity in 5-fold intensities indicated between one to five AuNCs bound cysteines at each 5-fold. 
According to the relaxed symmetry reconstruction, of those highly bound nanocapsids, between 40–70% of bind-
ing sites were occupied, with majority of 5-fold axes bound to one or more AuNC. Based on these findings, we 
modeled possible scenarios that would reflect the resulting AuNC distribution around the 5-fold (Fig. 5c).
Discussion
The higher conjugation efficiency of Au102_C6MI over short incubation time as shown in Fig. 2d was most likely 
attributed to the increased binding site accessibility of an extended C6MI linker. Though overnight conjugation 
increased Au102 binding efficiency, the observed reduction in conjugation efficiency of Au102_C6MI over time may 
be a consequence of precipitation. Au102_C6MI tended to precipitate in solution over time, particularly at high pH 
(Figure S2d). In addition, maleimide ring hydrolysis causing the ring to open and lose thiol reactivity will reduce 
binding efficiency34. The hydrophobicity of the C6MI linker may have induced hydrophobic surface interactions 
between functionalized AuNCs, contributing to Au102_C6MI precipitation in solution.
Rigid modeling of AuNC-bound nanocapsids revealed a localization of AuNC densities around the 5-fold 
symmetry center. In the first two models (Fig. 3a,b), gold densities form a ring of AuNC densities similar to 
that observed in our 3D reconstruction results (Fig. 4). However, the gold densities in these two models localize 
further away from the S-domain residues than observed in our experimental structure. Conversely, the gold den-
sities in the third rigid modeling structure (Fig. 3c) do not form a ring but localize closer to the 5-fold S-domain 
residues. This could be explained by limitations in rigid modeling parameters that did not allow overlap between 
probe density (including organic ligand surface) and nanocapsid residues. Potential attractive forces between 
the C6MI linker and 5-fold surface that cause the AuNCs to partially overlap with the S- domain would not be 
accounted for in the rigid models. The rigid modeling results revealing a ring-shaped density around 5-fold center 
supported the experimental reconstruction data.
Ligand exchange bioconjugation was previously described using Au144pMBA6014,15, a gold nanocluster similar 
to Au102. The surface thiol on Au144pMBA60 was conjugated to a small Fab fragment that specifically bound a neu-
raminidase protomer. Single particle reconstruction results of these AuNC-protein complexes validated the spec-
ificity and immobility of AuNC-bound protein. These results suggested AuNC conjugation could be employed to 
optimize high-resolution cryoEM structure determination16. Further supporting the claim of AuNC-protein com-
plex rigidity, we resolved the position of gold densities bound to the surface of nanocapsids at 12.8 Å resolution.
Figure 4. 3-D structure of nanocapsid T = 1, conjugated to AuNC (a) Surface rendering of 3D reconstructed 
volumetric map of nanocapsid bound to AuNC, depicting both the outer surface (left) and capsid interior 
(right). The shell, middle, and protrusion domains are radially colored with gray, dark blue, and cyan, 
respectively. Scale bar is 6.0 nm. (b) Non-orthogonal intensity slice analysis around 5-fold axis showing high 
intensity regions associated with AuNC. Overall diameter of each AuNC measured to be 2.5 nm and distance 
from bottom to top of 5-fold measured to be 3.3 nm. (c) Plane intensity analysis showing distinct high intensity 
regions with a total diameter of 5.9 nm and distance between each AuNC 2.9 nm. (d) Quantitative comparison 
of surface intensity around the 5-fold axis between nanocapsid with (left) and without AuNC (right). 
Nanocapsid-bound AuNC showing distinct peaks around the 5-fold, not observed in the no-AuNC map. (e) 
Quantitative 1D intensity histogram comparing nanocapsid-bound AuNC (gold line) with nanocapsid (gray). 
Intensity peak ~1.8 nm away from the center of the 5-fold, in good agreement with observed position of AuNC.
www.nature.com/scientificreports/
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The high intensity regions in the nanocapsid 5-fold revealed in 3D reconstruction were not observed in either 
the unbound nanocapsid x-ray crystal structure or the reference density volume of T = 1 nanocapsid29,35,36, sug-
gesting these intensities were attributable to bound AuNCs on the nanocapsid surface. The experimental meas-
urements determined in 3D reconstruction were compatible with the size of AuNC and its maleimide linker 
(Fig. 4b,c). The atomic radius of Au102 is about 1.3 nm with a 1.1 nm C6MI linker arm23, such that, the distance 
from the center of the AuNC gold core to the maleimide conjugation site is approximately 2.5 nm. Similarly, when 
measured at 100% mass, the high intensity region attributed to AuNC in the 3D reconstruction was approx-
imately 2.5 nm (Fig. 4b). A 2–3 nm distance between the maleimide binding site and the AuNC core density 
indicates the C6MI linkers extended from the binding site towards the 5-fold center without significant structural 
changes of the nanocapsid P-domain. The observation of intensities slightly above the S domain around the 5-fold 
center suggests bound AuNCs localized near neighboring AuNCs.
3D reconstruction with relaxed icosahedral symmetry indicated the AuNCs were not equally distributed 
around the nanocapsid 5-fold axes. The position of high intensities regions revealed in the relaxed symmetry 
structure was consistent with the imposed symmetry structure, but relaxed symmetry results suggested not all 
binding sites were occupied. These findings fit well with our SDS-PAGE and size exclusion results that indi-
cated incomplete AuNC binding. Qualitative cryoEM observations also indicated AuNC conjugation was not 
homogenous among nanocapsids. The observed heterogeneity of AuNC binding to nanocapsid was distinct from 
previously described enterovirus binding results where only 0% or near 100% AuNC occupancy was observed23.
The nanocapsid 5-fold forms a sizeable cavity suitable for AuNCs with limited steric hindrance. The S-domain 
that forms the 5-fold axis is comprised of key hydrophobic residues and is relatively neutral in charge25, likely 
resulting in attractive forces between the S-domain 5-fold residues and C6MI linkers. The partial hydropho-
bicity of Au102_C6MI likely contributed to attractive forces between neighboring AuNCs within the nanocap-
sid 5-fold. It was previously shown that, of the five cysteine replacement sites tested, 573 C functionalization 
with maleimide-biotin yielded the highest streptavidin binding signal6. It was proposed that 573 C conjugation 
resulted in multiple biotin conjugates localizing in the 5-fold, allowing the bound streptavidin to form its native 
tetrahedron structure above the 5-fold cavity. Our 3D reconstruction of AuNC-bound nanocapsids suggests that 
the 5-fold cavity is amenable to interactions between conjugate molecules without compromising the capsid 
structure.
AuNC conjugation optimization is critical to developing a stable, detectable delivery construct. A nanocapsid 
is conveniently sized to simultaneously anchor tissue-targeting ligands and detection molecules to the capsid 
surface5. AuNC detection molecules localized in the 5-fold cavity would not interfere with targeting molecules 
and/or foreign antigens chemically conjugated to the exposed dimer plateau. Nanocapsids were previously used 
Figure 5. 3D reconstruction of AuNC-bound nanocapsid based on relaxed symmetry TEM analysis. (a) 3D 
modeling of AuNC-bound nanocapsid with 5 AuNC clusters arranged around the 5-fold axis in a ring-shaped 
array. (b) Following relaxed symmetry 3D-refinement of AuNC-bound nanocapsid, 5-fold vertices show an 
uneven distribution of AuNC from the relaxed symmetry reconstruction. These vertices are colored based on 
slice intensity analysis with 5-fold vertices having between 0–5 intensities attributable to AuNCs. (c) Illustration 
of various scenarios based on relaxed symmetry TEM 3D reconstruction results. Radial cueing 120 Å away from 
the nanocapsid origin.
www.nature.com/scientificreports/
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to encapsulate delivery agents such as nucleic acids or negatively charged therapeutics4,5,35. This was achieved 
through reversible in vitro disassembly through chemical reduction and chelation, followed by the addition of 
negatively charged molecules and subsequent encapsulation via Ca2+ induced nanocapsid reassembly. This pro-
cess exploits the Ca2+ salt bridges formed in the nanocapsid 3-fold that are critical to icosahedral assembly. By 
designing a linker and binding site that orients the AuNCs towards the 5-fold, AuNC conjugation would not 
impede packaging through 3-fold disassembly and reassembly. Importantly, establishing the 5-fold localization of 
conjugated AuNCs is conducive to high resolution tracking of nanocapsid packaging in cryoEM.
By resolving the structure of the AuNC-bound complex, an opportunity arises for higher order surface tun-
ing with AuNCs. In a recent study28, a plasmonic AuNC, Au~250(pMBA)x (Au~250), was linked through disulfide 
bonding to form dimer and trimer multimers. Au~250(pMBA)x exhibits localized surface plasmonic resonance 
(LSPR) hallmarked by absorbance at 530 nm, which is considered a potentially useful signal for imaging bio-
logical samples13,37. Disulfide linkage between Au~250 resulted in plasmonic coupling in Au~250 monomers with 
unique UV-Vis absorbance at A620 nm and A800 nm. This red-shift resulting from hybridized plasmonic behavior 
was greater than expected based experimental data with colloidal gold. Absorbance in red to near-infrared (NIR) 
range is a spectral window of minimum water absorbance and minimized scattering, ideal for “deep tissue” and/
or in vivo imaging37,38. Nanocapsids could serve as a scaffold to orient similar plasmonic coupling interactions 
between AuNCs. As a diagnostic delivery system, a tumor targeted nanocapsid could be detected through LSPR 
and/or NIR detection. To control and optimize AuNC plasmonic coupling on the nanocapsid surface, it is critical 
to determine the position of AuNCs on the nanocapsid surface.
This study aided in the development of an efficient method for binding site selection, AuNC linker design, and 
AuNC conjugation to large icosahedral structures. The resolved structure of AuNC-bound nanocapsids offers 
insight for future ligand design, not only for additional conjugation, but also for coordination between bound 
AuNCs. Conjugation optimization and structural determination of AuNC-bound nanocapsids provided key 
insight in to the development of a theranostic nanocapsid delivery platform.
Methods
Nanocapsid Engineering and Production. Self-assembling nanocapsids were produced and purified fol-
lowing previously described methods39. Briefly, Hepatitis E Virus capsid protein sequence with 111 N-terminal 
and 52 C-terminal truncations (dORF2) was inserted in to the Baculovirus transfer vector (pFastBac/dORF2-
HEV). N573 was replaced with cysteine using Phusion® Site-Directed Mutagenesis (Thermo Fisher Scientific) 
and the resulting pFastBac/dORF2-HEV_N573C plasmid was transformed and amplified in MAX Efficiency® 
DH5α™ Competent Cells (Thermo Fisher Scientific. Plasmids were purified with Qiagen Mini-Prep Kit and 
sequenced at the UC Davis Sequencing Facility.
Following the Bac-to-Bac® Baculovirus Expression System protocol, pFBac/dORF-HEV_573 C plasmids were 
subsequently transposed in to MAX Efficiency® DH10Bac™ Competent Cells and screened twice for insertion 
in to the Bacmid vector (Bacmid/dORF2-HEV_573 C). Following the manufacturer’s protocol, purified Bacmid/
dORF2-HEV_573 C was transfected in to SF9 cells from the Izumiya lab for production of baculovirus recom-
bined with dORF2-HEV_573 C. Five-seven days after transfection, SF9/baculovirus supernatant was passaged 
two times in SF9 cells and collected three days post infection for baculovirus amplification.
A suspension culture of High Five insect cells was infected with amplified baculovirus supernatant for the 
production of HEV nanocapsids. High five cells expressing nanocapsid were harvested six days post infection. 
Nanocapsids were isolated from supernatant with previously described methods, using sucrose and cesium chlo-
ride gradient purification and NP-40 detergent treatment to remove lipids. SDS-PAGE was used to screen frac-
tions for purity and presence of nanocapsid depicted by 52 kDa banding. The storage and imaging buffer for 
nanocapsids was 10 mM MES pH = 6.2. Nanocapsids were imaged in TEM to confirm an intact T = 1 icosohedral 
structure was formed. The presence and exposure of nanocapsid cysteine was confirmed as previously described6.
Au102(pMBA)44 and Au102 C6MI Synthesis and Purifcation. Au102(pMBA)44 (Au102) was synthesized 
using previous methods17,40. In this work N-(6-hydroxyhexyl)maleimide was covalently bound via Steiglich ester-
ification reaction with p-mercaptobenzoic acid (pMBA) protected Au102 cluster to form Au102_C6MI23. Synthesis 
was done in dry DMSO/DCM in the presence of dicyclohexylcarbodiimide (DCC). The amount of linker mole-
cules per cluster cannot be accurately controlled but it was kept sufficiently low so that the functionalized clusters 
remained water-soluble.
Gel electrophoresis was run on 15% polyacrylamide gel (29:1, acrylamide:bisacrylamide) using 2X TBE buffer 
in a Bio-Rad Mini-Protean Tetra System gel electrophoresis apparatus at 130 V for two hours. All materials were 
commercial unless otherwise mentioned and used without further purification. Both Au102 and Au102_C6MI 
AuNCs were stored in dry conditions at RT or at 4 °C before conjugation. Specifically, Au102_C6MI was only solu-
bilized in a neutral pH solution immediately before conjugation to avoid the loss of maleimide function through 
hydrolysis.
Nanocapsid and AuNC Pre-Conjugation Preparation. AuNCs were diluted in sterile ddH20, 20 mM 
Tris-HCl/150 mM NaCl, PBS, or 10 mM MES. In the case that AuNC precipitate formed in buffer, serial pelle-
tation and resuspension was carried out to isolate soluble Au102_C6MI. The concentration of nanocapsids was 
determined with spectrophotometric absorbance measurements at A280nm followed by molar conversions based 
on the previously published molecular weight of T = 1 HEV_LP35. The concentration of solubilized AuNCs were 
determined with modified calculations based on previously described Au102 extinction coefficients at A420nm14,20.
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Prior to conjugation, nanocapsids were diluted 1:1 nanocapsid:neutral buffer (neutral buffer was either 
Tris-HCl/150 mM NaCl pH = 7.5 or PBS) and 1 mM TCEP final concentration. Nanocapsids in neutral 
buffer/1 mM TCEP were incubated at RT for 30 minutes-1 hour.
Nanocapsid Conjugation to AuNCs and Purification. Conjugation carried out 5 h or ON at RT 
or 4 °C. Gravity column chromatography and fractionation was used to separate unbound AuNC from 
nanocapsid-conjugated AuNC. Approximately 0.5–1 mL of GE Healthcare Sephacryl® S-500 HR size exclusion 
chromatography resin was serially washed with nanocapsid buffer (10 mM MES) and placed in Biorad Poly-Prep® 
Chromatography Columns pre-calibrated with sample buffer. In the column, the resin was serially washed and 
packed to form flat resin surface. Each droplet from the gravity column was separately collected such that each 
Eppendorf contained the same volume (35 μL). As a gravity-based method, time intervals between droplets was 
consistent over the course of collection. Individual fractions were assessed by spectrophotometry measurements 
and visible color change. Those fractions with peak A280nm and/or A420nm readings were screened with gel electro-
phoresis, and TEM imaging. Unbound AuNC remained in the column while nanocapsid and nanocapsid-bound 
AuNC eluted from column. Fractions were handled at 4 °C.
Spectrophotometry. For AuNC-bound nanocapsid samples, AuNC and nanocapsid concentration were deter-
mined by combining previously described calculation methods14 and Au102-specific extinction coefficient 
calculations20.
A420nm measurements were used indicate the concentration AuNC in the sample. A420nm was then used to infer 
the expected A280nm value based on known UV-Vis absorption energies20.
= .
= × .
=
 
+ −
LAuNC concentration A /33338 439 mol/
Expected A of AuNC A 2 072
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SDS-PAGE. Nanocapsid alone was run in reducing SDS-PAGE while samples containing AuNC was 
run in non-reducing SDS-PAGE. AuNC samples were prepared in non-reducing SDS loading dye (without 
β-mercaptoethanol or DTT) to protect the AuNC core from damage as previously described14. 52 kDa banding 
indicated the presence of nanocapsid, while a band ~56 kDa and visibly brown pre-coomassie blue staining indi-
cated AuNC-bound nanocapsid.
TEM. Samples were added to ionized continuous carbon grids, washed briefly with ddH20, and negatively 
stained with 2% uranyl acetate. Grids were then imaged on JEOL1230 Transmission Electron Microscope to 
confirm stability of nanocapsid structure35.
CryoEM Preparation and Imaging. CryoEM preparation and imaging was carried out using previously 
described methods35,41. Briefly, homemade lacey carbon coated grids and 200-Mesh Quantifoil® holey cabon 
grids were ionized with 40 mA glow discharge for 30 seconds. 1–2 mg/mL sample was added to the ionized grid 
for 30 seconds, blotted, and immediately plunged in to liquid nitrogen cooled liquid ethane using both manual 
and Virtobot® cryo-plunging methods. Nanocapsids embedded in a thin layer of vitrified ice were transferred 
to JEOL JEM-2300 microscope specimen chamber using a Gatan 626 cryo-transferring system. The sample was 
imaged with TVIPS CCD camera (TemCam-F415) under 60,000x magnification with a recorded pixel size of 
1.667 Å. The specimen was imaged with between 0.5–4 Å defocus level. The total dosage per image was approxi-
mately 60 electrons/ Å2. Alternatively, defocus pairs were imaged at 30 electrons/ Å2 dosage.
Rigid Modeling. To model Au102, a radial distribution function of atoms was generated using Gaussian dis-
tribution of 0.1 Å broadening parameter and the DFT-relaxed Au102(pMBA)44 coordinates. A simplified electron 
density of a single Au102 was generated using 10 Gaussians that match each of the atomic shell of the true radial 
distribution function. 7 Gaussians were used for Au-atoms, 1 for S-atoms, 1 for C-atoms, and 1 for O-atoms. 
H-atoms were neglected. Cumulatively, several thousands of possible Au102 positions was found and modeled 
electron density of a single Au102 was added to the allowed Au102-positions to generate the overall modeled elec-
tron density of Au102 bound to the CYS-sites around a single 5-fold symmetry axis of nanocapsid. This kind of 
density describes how the electron density of Au102 nanoparticles that are bound to the CYS-sites should look on 
average. While probe densities could not overlap with nanocapsid coordinates, the parameters required some 
point on the probe density was in contact with some point on the nanocapsid coordinates.
Reconstruction. From 113 micrographs, a total of 5276 raw projection images were selected via 
semi-automated particle selection tools using EMAN 2.1 package42. The selected particles were then screened 
manually and further segregated for quality by real space cross-correlation (CC) analysis from a set of projec-
tion images obtained from x-ray model36. After 7 cycles of refinement, particles with highest cross correlation 
values (CC), based on normal distribution were separated for the final 3D reconstruction. CC of + /− 20%, + /− 
15%, + /− 5% were progressively used to screen particles. Approximately 33% of selected particles were used in 
the final reconstruction. Progressively, during these refinement cycles, particles with + 5% RMSE of both center 
and orientation were excluded from the 3D reconstruction. The screened particles were further separated into 
subpopulations according to estimated diameter through scaling factor measurements, using the Polar Fourier 
Transformation (PFT) methods31. The population with the highest CC value and lowest root mean square error 
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(RMSE) in size variation were then low-passed to 20 Å to reduce background noise and were used to generate a 
low-resolution initial model though EMAN 1.9’s StartIcos program43. The refinement loop was optimized through 
a number of steps, gradually relaxing the low pass, verified by increased overall convergence. Furthermore, the 
orientation and center assignments for individual particles were carefully screened over the span of six cycles 
through the PFT method. A final radial search was conducted to isolate highly representative projection images, 
possessing high intensity peaks, most likely representing clusters of Au102 gold nanoparticles. The final resolu-
tion of the map was determined by Fourier Shell Correlation (FSC) via the even/odd split test via JSPR package32, 
estimated to 12.8 Å.
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